ArticleExperimental and therapeutic medicine2026
Risk factors for severe retinopathy of prematurity: A retrospective case-control study.
Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study aimed to investigate the risk factors associated with severe retinopathy of prematurity (ROP) in preterm infants and to identify predictive biomarkers for early risk stratification. The present retrospective case-control study analyzed preterm infants who underwent ROP screening at Hebei General Hospital (Shijiazhuang, China) between September 2018 and July 2023. Participants were stratified into mild (n=42) and severe ROP (n=38) groups based on fundus examination results and treatment requirements. Demographic characteristics, perinatal complications, maternal third-trimester lipid profiles and serial hematological parameters (within 24 h of birth and at 1 week of age) were analyzed. Binary logistic regression analysis was performed to identify independent risk factors, and receiver operating characteristic (ROC) curves were constructed to evaluate predictive performance. Significant differences were observed between severe and mild ROP groups in gestational age, birth weight and 1-min Apgar score (all P<0.001). Perinatal complications significantly associated with severe ROP included neonatal bronchopulmonary dysplasia (P<0.001), neonatal respiratory distress syndrome (P=0.003), neonatal sepsis (P=0.009) and blood transfusion requirements (P<0.001). Among hematological parameters, lymphocyte-to-monocyte ratio (LMR) was significantly lower in the severe ROP group both within 24 h of birth (P=0.015) and at 1 week of age (P=0.01). Multivariate logistic regression identified gestational age as the sole independent risk factor for severe ROP (P<0.001). ROC curve analysis revealed that gestational age ≤30.5 weeks predicted severe ROP with 76.2% sensitivity and 71.1% specificity (P<0.001). Maternal third-trimester lipid parameters showed no significant associations with severe ROP development. In conclusion, gestational age represents the most significant independent predictor of severe ROP in preterm infants, with infants born at ≤30.5 weeks showing significantly increased risk. Additional risk factors include major perinatal complications and altered inflammatory profiles characterized by reduced LMR. These findings support enhanced surveillance protocols for preterm infants and suggest the potential utility of inflammatory biomarkers in ROP risk stratification strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.